Literature DB >> 17409888

EGFR: a prognostic and/or a predictive marker?

Fred R Hirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17409888

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in non-small cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy.

Authors:  Nannan Guo; Wen Zhang; Baoshi Zhang; Yingjie Li; Jian Tang; Shaojun Li; Yingnan Zhao; Yunlong Zhao; Hui Xia; Changhai Yu
Journal:  Mol Clin Oncol       Date:  2015-07-21

2.  Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer.

Authors:  Chang-Sheng Lin; Tu-Chen Liu; Ji-Ching Lai; Shun-Fa Yang; Thomas Chang-Yao Tsao
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

3.  Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.

Authors:  A Kalikaki; A Koutsopoulos; M Trypaki; J Souglakos; E Stathopoulos; V Georgoulias; D Mavroudis; A Voutsina
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.